Nov 6 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2020 Sep 30, 2019 Dec 31, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 15 mln 168 mln 334 mln
(-91.0 pct) (+1903.4 pct) (+96.8 pct)
Operating loss 958 mln loss 1.21 loss 1.09
Recurring loss 978 mln loss 1.22 loss 1.09
Net loss 981 mln loss 1.20 loss 1.09
EPS loss 63.06 yen loss 101.88 yen loss 63.18 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Medrx.Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T